CLEVELAND, Ohio — A national study from Case Western Reserve University mapping epilepsy rates among older adults found that ...

GLP-1s are linked to lower seizure recurrence, hospitalization, and mortality risk than other glucose-lowering drugs in ...

Find out what to do if someone has a seizure and you're nearby.

A combination of missed prevention opportunities and health inequalities can result in the early deaths of people living with ...

Semaglutide, a GLP-1 receptor agonist (RA), was associated with a significantly lower risk for adult-onset epilepsy in patients with diabetes than other glucose-lowering drugs (GLDs). Notably, this ...

Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...

Focal-onset seizures (FOSs) are the most common type of seizure experienced by epileptic individuals. A recent randomized control trial published in JAMA Neurology evaluated the effect of a novel ...

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

Moving forward The CDC reports that one in 100 U.S. adults has active epilepsy, and studies suggest that one third of these are not receiving adequate treatment or care. 30 Although this recent report ...